Federal Supply Schedule 36F79724D0119
Award Date
6/1/24
Last Date to Order
5/31/29
Federal Agency
Veterans Integrated Service Network 12
Awardee
Insmed Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
Insmed Incorporated was awarded an indefinite-delivery vehicle to provide pharmaceuticals and drugs to various Department of Veterans Affairs networks and facilities through 2024. Under the Pharmaceuticals and Drugs Federal Supply Schedule, Insmed holds a blanket purchase agreement and multiple-award schedule contract with a combined value of $9.2M. Key products supplied include the antibiotic amikacin and ARIKAYCE, an inhaled liposomal formulation of amikacin used to treat nontuberculous...
This federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Insmed Inc., a global biopharmaceutical company specializing in rare respiratory diseases. The contract, valued at $49,323.45, provides for the delivery of the pharmaceutical product ARIKAYCE, a liposomal amikacin inhalation medication used to treat nontuberculous mycobacterial lung infections. This single-award BPA allows the VA to issue task orders...
The Department of Veterans Affairs (VA) has awarded Acorda Therapeutics, Inc., a biotechnology company specializing in neurological therapies, an IDV Federal Supply Schedule contract (36F79723D0194) valued at over $16.3 million. This multiple-award contract covers the procurement of drugs, pharmaceuticals, and hematology-related products through September 2028. Under this IDV, the VA Veterans Integrated Service Network 12 has issued firm fixed-price delivery orders for Acorda's Levodopa 42mg...
The Department of Veterans Affairs awarded a multiple-award federal supply schedule contract to Amryt Pharmaceuticals Inc. with a potential value of $225,000. The schedule is for pharmaceuticals and hematology-related products under contract number 65 IB. This enables ordering through September 2028. Additionally, the Department of Veterans Affairs National Acquisition Center awarded a single-award blanket purchase agreement to Amryt Pharmaceuticals with a value of up to $1,000,000. The BPA...
The Department of Veterans Affairs (VA) has awarded Amivas US LLC a five-year, $225,000 multiple-award Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs schedule (FSS-61-IB). This IDV allows VA medical facilities to issue task orders for Amivas' pharmaceuticals and hematology-related products. Amivas, a for-profit limited liability company, has prior experience providing pharmaceuticals and services related to clinical trials and medical research for federal agencies....
Actelion Pharmaceuticals US, Inc., a large pharmaceutical manufacturer, holds a $219,108,390 Federal Supply Schedule (FSS-61-IB) contract with the Department of Veterans Affairs (VA) and two Blanket Purchase Agreements (BPAs) valued at $118.5 million and $83.5 million. These Indefinite Delivery Vehicles (IDVs) enable the VA, Federal Bureau of Prisons, and other federal agencies to efficiently procure specialized pharmaceutical products, particularly treatments for rare diseases like pulmonary...
The U.S. Department of Veterans Affairs (VA) awarded Recordati Rare Diseases Inc., a foreign-owned pharmaceutical manufacturer, a $15.6 million multiple-award Federal Supply Schedule (FSS-61-IB) contract and a $3.1 million single-award Blanket Purchase Agreement to supply specialized orphan drugs and rare disease treatments. The contract vehicles allow the VA to efficiently procure Recordati's portfolio of medications, including Signifor LAR, Carbaglu, Cystadane, Isturisa, and Cystadrops,...
The key products and services being delivered under the federal contract IDV award to Amylyx Pharmaceuticals Inc. (doing business as Amylyx) are the procurement of RELYVRIO, an FDA-approved treatment for amyotrophic lateral sclerosis (ALS), for the U.S. Department of Veterans Affairs (VA). Amylyx, a self-certified small disadvantaged business, has secured multiple contract vehicles with the VA to facilitate the distribution of its pharmaceutical products to veterans, including a Federal Supply...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Amarin Pharma, Inc. as a multiple award against the Pharmaceuticals and Drugs schedule. The contract aims to procure drugs, pharmaceuticals, and hematology related products over a potential value of $4 million through February 2024. The contract provides access to Amarin Corporation P L C's portfolio of products through the Federal...
The Blanket Purchase Agreement was awarded by the Department of Veterans Affairs National Acquisition Center to Acorda Therapeutics, Inc. for the procurement of Inbrija and Ampyra. The contract has a potential value of $7.5 million and a period of performance through January 2024. The contract was awarded off the Pharmaceuticals and Drugs Federal Supply Schedule and provides a single award vehicle for ordering Inbrija, a treatment for off episodes related to Parkinson's disease, and Ampyra, a...